Roivant Sciences Ltd (NASDAQ:ROIV) has a beta value of 1.32 and has seen 6.69 million shares traded in the last trading session. The company, currently valued at $9.19B, closed the last trade at $11.41 per share which meant it lost -$0.22 on the day or -1.89% during that session. The ROIV stock price is -16.04% off its 52-week high price of $13.24 and 38.56% above the 52-week low of $7.01. If we look at the company’s 10-day average daily trading volume, we find that it stood at 17.59 million shares traded. The 3-month trading volume is 7.35 million shares.
Roivant Sciences Ltd (NASDAQ:ROIV) trade information
Sporting -1.89% in the red in last session, the stock has traded in the green over the last five days, when the ROIV stock price touched $11.41 or saw a rise of 3.31%. Year-to-date, Roivant Sciences Ltd shares have moved 1.60%, while the 5-day performance has seen it change 4.49%. Over the past 30 days, the shares of Roivant Sciences Ltd (NASDAQ:ROIV) have changed 6.84%. Short interest in the company has seen 31.57 million shares shorted with days to cover at 6.07.
Roivant Sciences Ltd (ROIV) estimates and forecasts
Figures show that Roivant Sciences Ltd shares have outperformed across the wider relevant industry. The company’s shares have gained 5.65% over the past 6 months, with this year growth rate of 34.81%, compared to 13.50% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -50.00% and -10.50% for the next quarter. Revenue growth from the last financial year stood is estimated to be 135.30%.
9 analysts offering their estimates for the company have set an average revenue estimate of $33.28 million for the current quarter. 8 have an estimated revenue figure of $47.61 million for the next quarter concluding in Jun 2024. Year-ago sales stood $27.38 million and $25.07 million respectively for this quarter and the next, and analysts expect sales will grow by 21.60% for the current quarter and 89.90% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 21.79% over the past 5 years.
ROIV Dividends
Roivant Sciences Ltd is expected to release its next earnings report between June 26 and July 01 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Roivant Sciences Ltd (NASDAQ:ROIV)’s Major holders
Insiders own 29.40% of the company shares, while shares held by institutions stand at 62.06% with a share float percentage of 87.90%. Investors are also buoyed by the number of investors in a company, with Roivant Sciences Ltd having a total of 311 institutions that hold shares in the company. The top two institutional holders are QVT Financial LP with over 122.54 million shares worth more than $1.24 billion. As of Jun 29, 2023, QVT Financial LP held 15.88% of shares outstanding.
The other major institutional holder is SB Investment Advisers (UK) LTD, with the holding of over 83.03 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $836.96 million and represent 10.76% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Growth Company Fund and Vanguard Specialized-Health Care Fund. As of Aug 30, 2023, the former fund manager holds about 1.33% shares in the company for having 10.3 million shares of worth $119.14 million while later fund manager owns 9.57 million shares of worth $114.67 million as of Jul 30, 2023, which makes it owner of about 1.24% of company’s outstanding stock.
